Consumers
Skin Care
Skin Cancer
Skin Conditions
Skin Treatments
Member Login
ASDSA Advocacy
Advocacy Activities
Back
Member Advocacy
Outreach
Back
External Relationships
Ignite Grants
Back
SUNucate Coalition
Back
State Legislation
Back
PULSE Coalition
Medical Spa Safety Coalition
Patient Safety Hero Awards
News You Can Use
Back
Support for Physician-led Care Teams in Dermatology
Tanning Bed Legislation for Minors: A Comprehensive International Comparison
CMS drastically increases IDR fees, releases preliminary report
Back
Back
Practice Affairs
Back
Cutaneous Procedures Adverse Events Reporting (CAPER) Registry
ASDSA Patient Safety Alert: Hyaluron pens and dangers to kids
Shared Decision-making Tools
Back
Positions & Model Legislation
Back
Position Statements
Model Legislation
Back
NEW: Medical Spa Safety Act
PULSE
SUNucate
Back
White Papers/Joint Consensus Statements
Back
Members Only
Back
CAPER and Adverse Event Reporting
Back
Search
ASDSA Advocacy
Positions & Model Legislation
White Papers/Joint Consensus Statements
Share
ยป
White Papers
Reconstitution of Botulinum Toxin Type A - November 2014
(PDF)
Sunscreen Use in Schools - May 2016
(PDF)
Joint Consensus Statements
Joint Position Statement on Safe In-Office Preparation of Buffered Lidocaine as a Local Anesthetic
(PDF, approved by the ASDSA Board of Directors, March 2019)
Consensus Statement on Blepharoplasty and Blepharoptosis Repair
(PDF)
Consensus Statement on Bundling Cosmetic Eyelid Surgery as a Part of Another Functional Procedure
(PDF)